Home
Publishing
DrugRxiv
Drug Repurposing
Network Medicine
About
REPO4EU
Meet the team
Drug Repurposing Research Collection
Conference
Blog
My ScienceOpen
Sign in
Register
Dashboard
Search
Home
Publishing
DrugRxiv
Drug Repurposing
Network Medicine
About
REPO4EU
Meet the team
Drug Repurposing Research Collection
Conference
My ScienceOpen
Sign in
Register
Dashboard
Search
15
views
0
references
Top references
cited by
8
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,388
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Arzneiverordnungs-Report 2007
other
Editor(s):
Ulrich Schwabe
,
Dieter Paffrath
Publication date
(Print):
2008
Publisher:
Springer Berlin Heidelberg
Read this book at
Publisher
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
REPO4EU Reports
Author and book information
Book
ISBN (Print):
978-3-540-72547-3
ISBN (Electronic):
978-3-540-72548-0
Publication date (Print):
2008
DOI:
10.1007/978-3-540-72548-0
SO-VID:
1dc6111e-9221-4e5d-8443-57519c329e8b
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. 3
Arzneiverordnungen 2006 im Überblick
pp. 37
Neue Arzneimittel 2006
pp. 111
Analogpräparate
pp. 149
Ökonomische Aspekte des deutschen Arzneimittelmarktes 2006
pp. 207
ACE-Hemmer und Angiotensinrezeptorantagonisten
pp. 233
Analgetika
pp. 249
Antiallergika
pp. 267
Antianämika
pp. 281
Antiarrhythmika
pp. 287
Antibiotika und Chemotherapeutika
pp. 313
Antidementiva
pp. 327
Antidiabetika
pp. 347
Antiemetika und Antivertiginosa
pp. 353
Antiepileptika
pp. 369
Antihypertonika
pp. 387
Antikoagulantien und Thrombozytenaggregationshemmer
pp. 403
Antimykotika
pp. 419
Antirheumatika und Antiphlogistika
pp. 439
Antitussiva und Expektorantien
pp. 459
Betarezeptorenblocker
pp. 473
Bronchospasmolytika und Antiasthmatika
pp. 493
Calciumantagonisten
pp. 505
Corticosteroide
pp. 513
Dermatika und Wundbehandlungsmittel
pp. 563
Diuretika
pp. 579
Durchblutungsfördernde Mittel
pp. 587
Gichtmittel
pp. 591
Gynäkologika
pp. 599
Hypnotika und Sedativa
pp. 613
Hypophysen-und Hypothalamushormone
pp. 623
Immuntherapeutika und Zytostatika
pp. 637
Kardiaka
pp. 643
Koronarmittel
pp. 651
Lipidsenkende Mittel
pp. 667
Magen-Darm-Mittel und Laxantien
pp. 695
Migränemittel
pp. 705
Mund- und Rachentherapeutika
pp. 715
Muskelrelaxantien
pp. 725
Ophthalmika
pp. 747
Osteoporosemittel
pp. 761
Parkinsonmittel
pp. 775
Psychopharmaka
pp. 821
Rhinologika und Otologika
pp. 835
Schilddrüsentherapeutika
pp. 845
Sexualhormone
pp. 869
Spasmolytika
pp. 875
Urologika
pp. 893
Vitamine und Mineralstoffpräparate
pp. 907
Überblick über die Arzneiverordnungen nach Arztgruppen
pp. 919
Arzneimittelverordnungen nach Alter und Geschlecht
pp. 935
Ergänzende statistische Übersicht
Similar content
1,388
Arzneiverordnungs-Report ‘93
Authors:
MJ LOHSE
Arzneiverordnungs-Report 1989
Authors:
U. SCHWABE
,
D Paffrath
,
M Anlauf
Lehrbuch der Pharmakologie, Toxikologie und Arzneiverordnung
Authors:
E. Starkenstein
See all similar
Cited by
7
Ökonomische Aspekte des deutschen Arzneimittelmarktes 2007
Authors:
Valentina Coca
,
Katrin Nink
,
Helmut Schröder
Ökonomische Aspekte des deutschen Arzneimittelmarktes 2010
Authors:
Valentina Coca
,
Katrin Nink
,
Helmut Schröder
Ergänzende statistische Übersicht
Authors:
Valentina Coca
,
Katrin Nink
See all cited by